Franck Priou

3.1k citations
29 papers · 2.4k · 3 hit papers · h-index 16

Impact in

Papers in

    • Prostate Cancer Treatment and Research 8
    • Renal cell carcinoma treatment 5
    • Cancer Treatment and Pharmacology 2
    • Cancer survivorship and care 2
    • PARP inhibition in cancer therapy 2

Franck Priou

29 papers receiving 2.4k citations

Franck Priou's Hit Papers

Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer 2021 · 581 citations
5810+4+8Years since publication100200300400500

Peers

Franck Priou
Comparison fields: 5 of 73
  • Pulmonary and Respiratory Medicine 1.4k
  • Cancer Research 447
  • Oncology 744
  • Radiology, Nuclear Medicine and Imaging 247
  • Hematology 82
Replace Francis X. Parnis with:
Francis X. Parnis Australia
Benjamin Louis Maughan United States
Andrea Juliana Gomes United States
Iris Kuss Germany
Shaun P. Tolan United Kingdom
Oana Petrenciuc United States
Voleak Choeurng United States
Martin Neil Reaume Canada
Sharon Beesley United Kingdom
Alan David Smith United Kingdom
Franck Priou relative to Francis X. Parnis Australia Francis X. Parnis's profile →
Citations per field
00.5×5×10×13.8×
Francis X. Parnis · 1×
Citations per year

Countries citing papers authored by Franck Priou

Since Specialization
Citations

This map shows the geographic impact of Franck Priou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franck Priou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franck Priou more than expected).

Fields of papers citing papers by Franck Priou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Franck Priou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franck Priou. The network helps show where Franck Priou may publish in the future.

Co-authors

The 25 scholars most cited alongside Franck Priou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Franck Priou Line = papers co-authored together Franck Priou links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
Hit paper breakdown →
2021581
2
Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial
Hit paper breakdown →
2013571
3
Androgen Deprivation Therapy (ADT) Plus Docetaxel Versus ADT Alone in Metastatic Non castrate Prostate Cancer: Impact of Metastatic Burden and Long-term Survival Analysis of the Randomized Phase 3 GETUG-AFU15 Trial
Hit paper breakdown →
2015375
4 2007153
5 2014131
6 2019106
7 2014100
8 201758
9 201455
10 200744
11 201239
12 200637
13 201927
14 201822
15 202520
16 201516
17 201716
18 202011
19 202311
20 20139

About Franck Priou

Franck Priou is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Reproductive Medicine and Epidemiology, having authored 29 papers that have together received 2.4k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (8 papers), Renal cell carcinoma treatment (5 papers), Breast Cancer Treatment Studies (4 papers), Multiple and Secondary Primary Cancers (2 papers), Ovarian cancer diagnosis and treatment (2 papers), Cancer Treatment and Pharmacology (2 papers), Cancer survivorship and care (2 papers) and PARP inhibition in cancer therapy (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.4k citations), Cancer Research (447 citations), Oncology (744 citations), Radiology, Nuclear Medicine and Imaging (247 citations) and Hematology (82 citations). Franck Priou has collaborated with scholars based in France, Belgium and Germany. Frequent co-authors include Frédéric Rolland, Stéphane Culine, Stéphane Marie. Oudard, Gwénaëlle Gravis, Laurence K. Albiges, Loı̈c Mourey, Florence Joly, Karim S. Fizazi, I. Krakowski and Jean-­Marc Ferrero. Their work appears in journals such as Annals of Oncology, European Journal of Cancer, European Urology, British Journal of Cancer and International Journal of Gynecological Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact